Pulmonx Corp — Director's Dealing 2023

Sep 6, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulmonx Corp (LUNG)
CIK: 0001127537
Period of Report: 2023-09-01

Reporting Person: French Glendon E. III (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-09-01	Common Stock	S	1031	$10.01	Disposed	1173516	Direct
2023-09-01	Common Stock	S	1575	$10.01	Disposed	1171941	Direct
2023-09-01	Common Stock	S	3921	$10.01	Disposed	1168020	Direct

Footnotes

F1: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on June 1, 2021.

F2: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2022.

F3: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2023.